Search

Your search keyword '"Pitt, Bertram"' showing total 1,632 results

Search Constraints

Start Over You searched for: Author "Pitt, Bertram" Remove constraint Author: "Pitt, Bertram" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
1,632 results on '"Pitt, Bertram"'

Search Results

1. Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

2. PANEL DISCUSSION

6. Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction

17. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF

23. Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

25. Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials

26. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

29. On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF

30. Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial

31. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial

34. Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis

40. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

41. The renin‐angiotensin‐aldosterone system and its suppression

42. Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction

43. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

44. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.

47. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

49. Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

50. Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population

Catalog

Books, media, physical & digital resources